Corvus Pharmaceuticals Inc
Research Corvus Pharmaceuticals Inc (CRVS) on Bullrun: market cap USD 1.22B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCRVS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.22B
- Financial periodFY2025
- Net income-USD 15.30M
- Free cash flow-USD 32.97M
Valuation Snapshot
latest market cap is USD 1.22B.
About Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.
Frequently asked questions
What is Corvus Pharmaceuticals Inc's market cap?
Corvus Pharmaceuticals Inc's market capitalization is USD 1.22B.
What does Corvus Pharmaceuticals Inc do?
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.